| I-01 Ana Alarcia Lacalle Population pharmacokinetic modelling of levetiracetm in criticaclly ill patients. Influence of creatinine clearance on the probability to attain target concentrations. |
| I-02 Michael Cloesmeijer Capped dosing of desmopressin in Von Willebrand disease: Quantification of the relationship between desmopressin plasma concentration and Von Willebrand factor activity |
| I-03 Alix Démaris Simulation based assessment of different dosing strategies for anti-TNFα monoclonal antibodies in Crohn’s disease patients |
| I-04 Thomas Dumortier A model-based approach to support a label update for flexible dosing of secukinumab in patients with plaque psoriasis |
| I-05 Omar Elkayal Population pharmacokinetics of cefazolin in maternal and umbilical cord plasma, and exposure in term neonates |
| I-06 Ruben Faelens Building model-informed precision dosing software using R: blueprint for a state-of-the-art development process |
| I-07 Wannee kantasiripitak A multi-model averaging approach improves the performance of model-guided infliximab de-escalation in patients with inflammatory bowel diseases |
| I-08 Simon Koele Pharmacokinetically-guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients |
| I-09 Matthias König A physiologically based computational model of indocyanine green liver function tests predicts survival in hepatectomy |
| I-10 Enrica Mezzalana Population pharmacokinetic modelling and simulation of imeglimin in type 2 diabetes patients to support dose recommendations to patients with renal impairment |
| I-11 Robin Michelet Using microdose-based activity measurement to individualise dosing of cytochrome P450 metabolised drugs: a case study with yohimbine and tamoxifen |
| I-12 Sami Ullah Population pharmacokinetics suggests that an intraperitoneal daily dose of 750 mg meropenem is sufficient to treat peritonitis in patients undergoing automated peritoneal dialysis |
| I-13 Muhammad Usman Population pharmacokinetics of vancomycin in Pakistani patients: Dosing simulations based on renal status |
